Colgate-Palmolive (NYSE:CL) Shares Acquired by Kovack Advisors Inc.

Kovack Advisors Inc. increased its position in shares of Colgate-Palmolive (NYSE:CL) by 4.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,450 shares of the company’s stock after acquiring an additional 202 shares during the period. Kovack Advisors Inc.’s holdings in Colgate-Palmolive were worth $462,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. M&G Plc acquired a new position in Colgate-Palmolive during the 1st quarter worth approximately $3,812,000. Gordian Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $602,000. Vontobel Holding Ltd. raised its position in Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares in the last quarter. PGGM Investments lifted its stake in shares of Colgate-Palmolive by 171.8% in the second quarter. PGGM Investments now owns 157,608 shares of the company’s stock valued at $15,294,000 after purchasing an additional 99,624 shares during the period. Finally, QRG Capital Management Inc. lifted its position in shares of Colgate-Palmolive by 11.2% during the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock valued at $5,558,000 after acquiring an additional 5,751 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $91.44 on Friday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s 50-day moving average price is $99.94 and its 200 day moving average price is $98.48. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The firm has a market cap of $74.71 billion, a price-to-earnings ratio of 26.20, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. Evercore ISI raised their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Sanford C. Bernstein boosted their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.